You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

August 24, 2015

Front-of-Package Labeling in Thailand

Informed Counsel

Expanding waistlines and increasing health awareness have given rise to a consumer culture infatuated with well-being, not only in Thailand but all over the world. For producers, this means intense pressure to create healthy or healthier versions of their products. For the government—specifically the Thai Food and Drug Administration (FDA)—this means an obligation to implement and enforce stricter regulations on food and nutrition.

The Thai Perspective

As we move into an age where life is increasingly fast-paced, there is no reason why the food industry should be left behind. While nutritional labels are often displayed on the back of packaging, Front-of-Package (FOP) labeling has become popular among policy makers because it simplifies the most important information and places it where it is visible at first sight to the hurried consumer. In Thailand, the original 1998 Notification of the Ministry of Public Health (MOPH) implemented non-FOP nutritional labeling requirements which were mandatory for certain foods and voluntary for others. A survey conducted in 2009, however, concluded that the nutritional information was difficult to understand, which caused the FDA to make a number of changes.

In a series of subsequent ministerial notifications, the FDA implemented the Guideline Daily Amount (GDA) system of labeling, an FOP system that made GDA labels mandatory for snack products and certain ready-to-eat foods. The current GDA label breaks down nutritional information into four categories: calories, sugars, fats, and sodium. This requires producers to clearly state the nutrient content and percentage of recommended daily intake per package.

FOP Labeling Around the World

Countries around the world have also introduced policies which mirror the objectives of the GDA system of labeling to help consumers make the “smart” choice quickly. For example, the European Union takes the same approach as Thailand, basing its guidelines on the latest published scientific data on dietary requirements and recommendations. Similarly, the United States uses a voluntary Facts Up Front labeling system, which calls for a summary of calories, saturated fat, sodium, and sugar per serving on the front of various food and beverage products.

Singapore, on the other hand, uses the Healthier Choice Symbol, an interpretive nutrition logo which distinguishes products that are lower in saturated fat and trans fat, sodium, and sugar, but higher in whole grains, fiber, and other healthy nutrients. Nutrition guidelines are set according to each product category. There are 12 main product categories and more than 70 subcategories. In addition, there are variants including the Healthier Snack Symbol and the Healthier Ingredient Symbol.

Australia and New Zealand use the Daily Intake Guide and the Health Star Rating. The Daily Intake Guide is a voluntary scheme which uses a set of reference values for acceptable levels of intake for energy and a variety of nutrients, sugars, protein, fat, fiber, and sodium, to name a few. The Health Star Rating system was developed to make it easier for consumers to compare similarly packaged food and therefore make healthier decisions. It ranks products on a scale from half a star to five stars based on their nutritional profile which includes, for example, energy, saturated fat, and sodium. This system of labeling is a hybrid of the GDA system used by Thailand, the European Union, and the United States, as well as the Healthier Choice Symbol used by Singapore.

The Future of FOP Labeling

The food and beverage community has pushed to revamp the current FOP labeling scheme in Thailand. Currently, the National Food Committee, a subcommittee of the Thai FDA, is working to add to the present FOP GDA labeling scheme, but the additions have yet to be announced. It is known, however, that use of the new FOP label will be voluntary and presently it is only being considered for certain foods. Some organizations are looking for inspiration in the “traffic light” nutritional labeling system, a system that uses the colors red, amber, and green to indicate high, acceptable, and low levels of fat, saturated fats, sugar, and salt in various products. Foods with “green” indicators are healthier than foods with “red” indicators, while foods with “amber” indicators fall in between.

The Federation of Thai Industries Food Group has supported the use of GDA nutrition labels and is determined to become involved in educating consumers about the GDA system of labeling. It prefers the GDA system of labeling to a color-coded system or an interpretive nutritional logo because these are sometimes misleading and vague and often do not comprehensively take into account different nutritional needs.

The good news is that the industry has been invited to participate in the development of a new scheme which producers can both contribute to and benefit from. With the correct industry input, FOP labeling should offer consumers informative nutritional information that is apt for a fast-paced world.

RELATED INSIGHTS​ 

October 15, 2025
The Indonesian Food and Drug Administration (BPOM) has introduced more stringent oversight of health supplements containing probiotics with new guidelines that require clinical trials for certain products and expanded documentation standards. BPOM Regulation No. 17 of 2025 replaces the previous 2021 regulation and establishes a comprehensive framework for evaluating probiotic strains used in health supplements. Assessment Requirements The new regulation expands the scope of assessment to include not only categorization and documentation but also technical procedures, strain classification, and clinical trial requirements. Unlike the previous regulation, which provided general guidance, the updated framework creates a comprehensive system for evaluating both registered probiotic strains and new or combined strains. Manufacturers must now submit supporting documentation covering strain identification and functional characterization, safety, efficacy, and product quality. The previous regulation required documentation only on safety, efficacy, and quality. Clinical Trials One of the most significant changes is the requirement for clinical trials conducted in Indonesia for applications that include benefit claims other than maintaining digestive health, or where there are modifications to benefit claims. The regulation specifies that phase 1 trials must demonstrate safety, while phase 2 trials must validate efficacy using statistically valid methods such as double-blind, randomized, placebo-controlled studies). In addition, phase 3 and phase 4 trials may be required, and postmarket surveillance data must be submitted. Technical Assessment Framework Annex 4, a newly introduced section, establishes technical procedures for assessing health supplements containing probiotics in Indonesia. This comprehensive framework outlines criteria for evaluating new probiotic strains, including strain identification, functional characterization, safety, efficacy, and product quality. The annex introduces a clear classification of claims for health supplement products containing probiotics: General claims(e.g., maintaining digestive health). Functional claims(e.g., normal biological function or activity in the body). Risk reduction claims(e.g., lowering disease risk). The regulation restricts use of the term
October 3, 2025
On September 26, 2025, the Contract Committee under Thailand’s Consumer Protection Board issued a regulation that aims to standardize contracts and enhance consumer protection within the beauty and wellness industry. The Notification on Prescribing the Beauty Service Business as a Contract-Controlled Business B.E. 2568 (2025), which takes effect on January 24, 2026, requires business operators to use a prescribed standard contract in Thai and adhere to strict mandatory provisions and prohibitions. These regulations apply to operators across all in-person and online service channels, including via digital platforms. “Beauty services business” is defined as the provision of services under an agreement allowing consumers to receive a series of treatments, either over a set number of sessions or within a set period. This includes massage, spa, other methods for cleanliness, beauty, or care of facial or body skin, and weight control and body shaping—including services offered electronically. The law excludes surgery, liposuction, and medical treatments performed by licensed practitioners. The notification establishes the following key requirements: Mandatory contract and formatting. All contracts with consumers must use the standard contract form, in Thai, with clear, readable text (minimum font size of 2 millimeters, no more than 11 characters per inch), and include all essential terms from the annexed form. Contract execution. Contracts must be made in duplicate, with one copy given to the consumer at signing. For agreements concluded through electronic channels, the process must comply with the Electronic Transactions Act and use the same required terms. Digital platforms. Business operators who provide services facilitated through a digital platform as an intermediary are ultimately responsible for ensuring the consumer receives a compliant contract. Prohibited clauses. The law prohibits clauses that limit or exclude liability for damages to life, body, health, mind, or property resulting from breach of contract or a wrongful act;
September 16, 2025
Since Thailand formally removed Mitragyna speciosa (kratom) from the list of narcotic drugs, the country has progressed from outright prohibition to a structured, license-based regime. While the Ministry of Public Health oversees cannabis plant regulation, the Ministry of Justice (MOJ) is the regulatory authority overseeing kratom plants. For the avoidance of doubt, separate Ministry of Public Health notifications prohibit the use of kratom as a food ingredient unless a food safety evaluation has been conducted; however, this restriction does not affect trade in unprocessed leaves per se. For businesses in Thailand dealing exclusively in kratom leaves, the most consequential development is the Ministerial Regulation on the Application for Permits and Notifications for the Importation and Exportation of Kratom Leaves B.E. 2568 (2025), a bylaw of the Kratom Plant Act 2022. The ministerial regulation establishes the following notable definitions: “Kratom leaves”: Fresh or dried leaves in their natural, unprocessed state (no extracts, concentrates, or infused products). “Import/Export”: Any act of bringing kratom leaves into or out of Thailand, whether for commercial sale, industrial processing abroad, or research. Import/Export Licensing Under the Kratom Plant Act, a license is mandatory for importing or exporting kratom leaves. Individuals, juristic persons, community enterprises, and state agencies in Thailand are eligible to obtain a license to import (or a license to export) kratom leaves. Licenses are available to qualified individuals and juristic persons. Individuals must satisfy the following qualifications to be eligible for a license: Thai nationality, ≥ 20 years old, resident in Thailand. Not incompetent, quasi-incompetent, or under legal guardianship. No license suspension currently in force under the Kratom Act or Narcotics Code. No license revocation in the previous two years. No conviction under the Kratom Act or Narcotics Code within the previous two years (unless fully released from punishment). Juristic persons must satisfy
September 4, 2025
With advancements in health technology, telemedicine has taken on a wider online presence in Thailand. Under the Medical Facility Act, licensed clinics and hospitals may now diagnose, prescribe, and issue electronic prescriptions during a video call, provided they maintain patient confidentiality and proper recordkeeping. As a complementary concept, a telepharmacy allows a pharmacist to verify prescriptions, counsel patients, and dispense medication from a remote site. Hospitals, clinic chains, and some retail pharmacy groups have adopted “drive-thru” or “locker” pick-up points where drugs are bagged only after a real-time video consultation with a registered pharmacist. The clear benefits of telehealth include shorter waiting times and broader access to specialists, which is in the public interest. Drug Distribution and Advertising in Thailand The online pharmacy ecosystem creates a legal bridge in that once a teleconsulting doctor issues an e-prescription, a licensed pharmacy can lawfully dispense and deliver the medicine prescribed to the patient’s door. Nonetheless, the critical compliance component remains the advertising of medicinal drugs. It is still not allowed to advertise prescription/pharmacy-dispensed drugs to the public in Thailand. Although Thailand’s Drug Act of 1967 was written more than half a century ago, it still governs the trading of every medicinal drug that makes its way to consumers in Thailand—whether bought at a pharmacy or delivered with a few taps on a smartphone. First and foremost, the pharmacy must hold a license to sell medicinal drugs as a retailer. It is also mandatory that arrangements be made for a pharmacist to be on duty during opening hours. Drugs are classified into three main categories: prescription drugs, pharmacy-dispensed drugs, and over-the-counter (OTC) drugs. The listing of OTC drugs with their prices via an online platform is allowed, as only OTC drugs may be advertised directly to the public. However, naming or showing